We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novavax Inc | NASDAQ:NVAX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.26 | -5.46% | 4.50 | 4.49 | 4.50 | 4.94 | 4.475 | 4.94 | 3,842,987 | 19:48:28 |
From May 2019 to May 2024
Presentation details are as follows:
Date: Tuesday, September 26, 2017Time: 11:00 – 11:25 am ETLocation: Track 5, Montmartre, Sofitel Hotel, New York CityLive webcast: www.novavax.com, “Investors”/“Events”
A replay of the presentation will also be accessible under the “Investors/Events” section of the Novavax website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.
Contact:
Investor RelationsNovavax, Inc.Andrea N. Flynn, Ph.D.Director, Investor & Media Relationsir@novavax.com240-268-2000 Westwicke PartnersJohn Woolfordjohn.woolford@westwicke.com443-213-0506
MediaRusso Partners, LLCDavid SchullMaggie Bellerdavid.schull@russopartnersllc.com maggie.beller@russopartnersllc.com212-845-4271
1 Year Novavax Chart |
1 Month Novavax Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
